Tag: marvel

Black Panther: Wakanda Forever Box Office Prediction

Blogger’s Note (11/09): I am revising my estimate down from $205.2M to $195.2M. As opposed to the narrative below, that would now give it the #9 opening of all time behind its 2018 predecessor.

On November 11th, Black Panther: Wakanda Forever looks to score the second largest opening of the young decade and add another MCU pic to the top 10 debuts of all time. The sequel to 2018’s phenomenon has Ryan Coogler returning to the director’s chair. Early reactions are very positive saying that part 2 pays touching tribute to Chadwick Boseman, who played the title character in the original and passed away in 2020. Letitia Wright, Lupita Nyong’o, Danai Gurira, Winston Duke, Dominique Thorne, Tenoch Huerta, Martin Freeman, and Angela Bassett are among the large cast.

Wakanda is not expected to approach the $260 million that Spider-Man: No Way Home made out of the gate last December. It should, however, get beyond the $191 million that Doctor Strange in the Multiverse of Madness earned in May. If it does, it would land the #2 opening of the decade and the pandemic era.

In February of 2018, Black Panther rode a wave of sizzling buzz to a $202 million start over the Friday to Sunday portion of President’s Day weekend. For the four-day frame, it topped out at $242 million before eventually grossing $700 million domestically. The three-day premiere still stands at #8 all-time while the overall haul is 6th.

I do believe that all the Wakanda stars are lining up for a Friday to Sunday take that surpasses the original by a small margin. My estimate would give the new Panther the #8 opening while moving its predecessor down to ninth. Time will tell if it eventually approaches the $700 million that the first part amassed.

Black Panther: Wakanda Forever opening weekend prediction: $195.2 million

Morbius Review

There are some Matrix adjacent fight scenes in Morbius that might have you thinking it should be called Morpheus. They’re nowhere near that level in quality and some of them are such a CG mess that you can’t tell what’s happening. Should our hero and villain bite the red artery or suck the blue vein? Despite its connective tissue to Sony’s Spider-Man Universe (meaning the web slinger and Venom), it’s hard to really care.

Dr. Michael Morbius (Jared Leto) is a world renowned expert in blood disorders. The experience is personal as he has one and makes it his life work to cure himself and others. His childhood friend Milo (Matt Smith) suffers from the same disease and has the money to bankroll Doc Mo’s research. A Costa Rican excursion results in the acquisition of vampire bats. Perhaps some genetic splicing will do the trick!

This is when Morbius is blessed and cursed with the batty sense. He feels better than ever (and looks jacked), but has to feast to keep the strength up. His desire to go full Dracula prevents him from offering the cure to Milo. That puts a strain on their friendship causing Milo to go full overacting bad guy.

While our title character tries to get by on artificial blood, many of the visual effects look pretty fake. There’s no real development of the supporting characters. This includes Adria Arjona as Morbius’s colleague/love interest, Jared Harris as his father figure and medical mentor, and Tyrese Gibson and Al Madrigal as detectives tracking the suckers. Maybe their time was cut. Maybe the filmmakers (with Daniel Espinosa in the director’s seat) are saving some for hoped for sequels. Tyrese is apparently signed for a three-picture deal which explains his curiously fast appearance.

In the first half, Morbius is a passable enough monster mash. Maybe even a little quaint as it sort of feels like a late 90s genre piece before most comic book movies came with $200 million budgets. I’m not sure I buy Leto as a brilliant physician turning down Nobel prizes, but he doesn’t embarrass himself. This sputters as the effects render it increasingly incomprehensible.

By the time it drops in Spidey references in the mid credits sequences, it’s gotten desperate. In this Spider-Verse, Morbius doesn’t reach the specific heights of the venomous creatures preceding it.

** (out of four)

Morbius Box Office Prediction

Sony and Marvel are hoping there’s plenty of buyers in the Morbius club as the dark superhero tale finally premieres on April 1st. Led by Jared Leto in the title vampiric role, Daniel Espinosa directs with a supporting cast including Matt Smith, Adria Arjona, Al Madrigal, and Tyrese Gibson.

This is the third entry in Sony’s Spider-Man Universe after the two Venom flicks from 2018 and last year. Both of them were massive hits and, of course, we are on the heels of Spider-Man: No Way Home being the third largest domestic earner in history.

Morbius was originally set for release all the way back in summer of 2020 before its numerous COVID related delays. Shot for a reported $75 million, it should have no trouble making its money back (especially when including international grosses). Yet I’m skeptical it approaches the $80 million that Venom started with or $90 million that its sequel earned out of the gate a few months back.

Estimates are in the $40-$50 million range and my hunch is that projecting a debut in the middle end of that range is the call.

Morbius opening weekend prediction: $45.8 million

Venom: Let There Be Carnage Review

There’s a sequence in Venom: Let There Be Carnage where Woody Harrelson’s serial killer villain engages in mayhem with his crazy girlfriend (Naomie Harris). The deadly duo wreak their havoc in a ’66 Mustang and, for a moment, I was reminded of the actor’s appearance nearly 30 years ago in Natural Born Killers. Call it Muckey and Mallory this time as the amount of extraterrestrial goo is easily doubled in this sequel.

Speaking of natural born killers, it’s an apt description for the title character. The alien symbiote longs to bite humans heads off, but he’s mostly under control due to his human host Eddie Brock (Tom Hardy). Poor Venom has to settle for chickens. Continuing the banter that was the highlight of the original, Carnage still allows for Hardy’s bizarre but oddly effective comedic performance.

For those who forgot (and 2018’s Venom was a bit forgettable), Eddie is a San Francisco based journalist whose expose into scientific experiments stuck him with the black liquid alien that now lives in his body. Our loony reporter is put on assignment when Detective Mulligan (Stephen Graham) tasks Eddie with extracting evidence from death row condemned psycho Cletus Kasady (Woody Harrelson).

Their jailhouse interview leads to chaos and Carnage – as in the name of a Venomous offspring that invades the already crazed Cletus. And there’s the aforementioned love interest played by Harris. Confined to the Ravencroft Institute (where we first met Cletus in a Venom post-credits bit), Frances Barrison can manipulate sound to get herself out of sticky situations. This earns her the moniker Shriek due to those deadly decibels.

Andy Serkis is in the director’s chair (replacing Ruben Fleischer) and he keeps Carnage short, light, and full of CG action. The screenplay strains a little to justify bringing back Michelle Williams as Eddie’s ex-flame. I suppose someone’s gotta get saved by the hero in the third act. Reid Scott reprises his role as her boyfriend and there are a couple of humorous moments with his character.

I couldn’t quite recommend Venom though I came close solely based on Hardy’s batty work. This is no comic book masterwork and even the great Harrelson’s villainous turn is passable at best. Yet I more or less came around with Carnage. I give it props for foregoing a bloated running time (it’s just an hour and a half). It’s hard to not be entertained by Hardy and his skull chomping companion. In the constantly growing universe of comic book based franchises, it’s getting common for the sequels to improve upon the originals. The first entries always have to go through the origin story while the follow-ups can be a little more fun. That applies here.

*** (out of four)

October 8-10 Box Office Predictions

Blogger’s Note (10/06): I have revised my No Time to Die prediction from $104.1 million down to $94.1 million, which would still set a COVID era record.

After the absolutely fantastic and record breaking performance of Venom: Let There Be Carnage, James Bond looks to set his own high mark this weekend with the 25th 007 adventure No Time to Die. You can peruse my detailed prediction post on it here:

No Time to Die Box Office Prediction

Daniel Craig’s fifth and final contribution to the storied franchise has been climbing up with my estimates. Early last week, I figured it would do $72.1 million (good for second in the series after the $88 million achieved by Skyfall). By Friday, I went with $84.1 million. Following what Tom Hardy’s superhero sequel did, I am now figuring this will be the first Bond feature to debut north of $100 million.

There are potential obstacles. It certainly has a longer runtime than Venom. We would be in new territory for this franchise with a gross that enormous. That said, no one foresaw the Venom follow-up hitting $10 million more than its predecessor. I also believe the hoopla surrounding Die being Craig’s swan song (and the solid reviews) will only help.

The original Venom fell 56% in its sophomore in October 2018 to $35 million. Competition this time around is steeper and I do believe a 60% or more dip is certainly possible (thought it could continue to confound expectations).

After a decent debut, The Addams Family 2 will be third and I’d look for a drop in the mid 40s range (similar to its predecessor from 2019). Shang-Chi and the Legend of the Ten Rings should hold the 4 spot with The Many Saints of Newark (after a subpar showing) in the 5 position.

Here’s how I envision the chart playing out:

1. No Time to Die

Predicted Gross: $94.1 million

2. Venom: Let There Be Carnage

Predicted Gross: $33.7 million

3. The Addams Family 2

Predicted Gross: $9.2 million

4. Shang-Chi and the Legend of the Ten Rings

Predicted Gross: $3.4 million

5. The Many Saints of Newark

Predicted Gross: $1.8 million

Box Office Results (October 1-3)

I’m pretty sure the number $58.7 million is going to haunt me for awhile. That’s what I said Venom: Let There Be Carnage would gross out of the gate and, umm, I was a little low. As mentioned, the Tom Hardy sequel set a pandemic era best haul with a cool $90 million (topping the $80 million of part 1 and the COVID times best $80 million achieved by Black Widow). I think it’s safe to say get ready for part III as champagne corks are popping over at Sony.

The Addams Family 2 couldn’t come close to the $30 million start of part 1, but it wasn’t expected to. The $17.3 million output is right in line with the best of expectations and slightly ahead of my $16.6 million projection.

Shang-Chi and the Legend of the Ten Rings was third with $6.1 million (I was higher at $7.6 million) for $206 million total. It’s the first pic to reach the double century milestone domestically since COVID.

Sopranos prequel The Many Saints of Newark was a theatrical dud at just $4.6 million for fourth. I went considerably north of that with a $8.6 million projection. Look for this to fade fast as HBO hopes its Max subscribers stream it on their service.

Dear Evan Hansen tumbled badly in weekend 2 with $2.4 million. Again I was generous with $4.2 million. That’s a troubling 67% decline after a weak opening and the tally is $11 million.

And that does it for now, folks! Until next time…

Venom: Let There Be Carnage Box Office Prediction

Arriving one year after its COVID delay, Tom Hardy returns as the Marvel Comics title character in Venom: Let There Be Carnage. The sequel includes returnees Michelle Williams and Reid Scott along with newcomers Naomie Harris, Stephen Graham, and Woody Harrelson (who did briefly cameo in the original’s post credits scene). Andy Serkis, certainly no stranger to CG effects, takes over directorial duties from Ruben Fleischer.

Three years ago, Venom surpassed expectations with a then October best opening weekend of just over $80 million. That record was beaten a year later by Joker. The overall domestic gross of $213 million guaranteed a follow-up.

After witnessing the recent robust performance of Marvel’s Shang-Chi and the Legend of the Ten Rings, Sony actually pushed up the release date by two weeks.

Carnage kicks off a month where studios are hopeful for pleasing returns with heavy hitters like No Time to Die, Halloween Kills, and Dune. I don’t envision this getting to $80 million like its predecessor. A more realistic expectation would be part II nabbing about 75% of what part I achieved out of the gate.

That would be $60 million and I’ll say it goes just under that.

Venom: Let There Be Carnage opening weekend prediction: $58.7 million

For my The Addams Family 2 prediction, click here:

The Addams Family 2 Box Office Prediction

For my The Many Saints of Newark prediction, click here:

The Many Saints of Newark Box Office Prediction

September 24-26 Box Office Predictions

Marvel’s Shang-Chi and the Legend of the Ten Rings looks to make it a clean sweep at #1 for the month of September this weekend. The only competitor standing in its way is Dear Evan Hansen, the adaptation of the hit Broadway musical. You can peruse my detailed prediction post on it here:

Dear Evan Hansen Box Office Prediction

The fact that Hansen is garnering mixed reviews has me questioning whether it reaches double digits. I’m guessing no and that should put it in the runner-up position behind Rings, which may only drop in the low 30s.

Holdovers will populate the rest of the five as we await some potential October behemoths starting with Venom: Let There Be Carnage and continuing with No Time to Die, Halloween Kills, and Dune.

Until then, expect a rather quiet end to this month at multiplexes. Here’s how I envision the top five:

1. Shang-Chi and the Legend of the Ten Rings

Predicted Gross: $14.9 million

2. Dear Evan Hansen

Predicted Gross: $8.6 million

3. Free Guy

Predicted Gross: $4.5 million

4. Cry Macho

Predicted Gross: $2.8 million

5. Candyman

Predicted Gross: $2.5 million

Box Office Results (September 17-19)

Shang-Chi steamrolled the rest of the weak competition in its third frame with $21.6 million. That’s just above my $20.1 million projection as the MCU juggernaut has amassed $176 million thus far with $200 million easily in its sights.

Free Guy dipped a scant 9% for second place in its sixth weekend with $5 million (I said $4.2 million). It has crossed the nine digit mark at $108 million.

The weekend’s top newcomer was Clint Eastwood’s Cry Macho with a ho-hum $4.4 million compared to my more generous $6.4 million estimate. Perhaps its intended older demographic opted to view it on HBO Max or, with its mixed reviews, not at all.

Candyman was fourth with $3.5 million, holding up better than my $2.6 million take. Total is $53 million.

Keeping with the horror theme, Malignant dropped 50% in its sophomore weekend with $2.7 million. That’s decent for its genre and it’s generated plenty of chatter (good and bad) that might have assisted in a curiosity factor. In two weeks, it’s made $9 million. I incorrectly had it outside the top five.

That’s because Gerard Butler’s latest action thriller Copshop (despite a decent critical response) tanked with only $2.3 million in sixth. I went with $4.5 million.

And that does it for now, folks! Until next time…

Oscar Watch: Nomadland

Ever since Nomadland was announced, it has been seen as a serious contender for the 2020 Oscars in multiple categories. This is Chloe Zhao’s follow-up to her acclaimed The Rider and it’s premiering all over the festival circuit this weekend (including Toronto and Venice) prior to its planned December 4th release. Based on reviews trickling out this afternoon, it’s living up to the hype.

The pic casts McDormand as a Nevada widow traveling the country in her van and critical reaction indicates it’s a tour de force performance from the two-time Best Actress winner. As you’ll recall, she took the gold statue in 1996 for Fargo and just three years back in Three Billboards Outside Ebbing, Missouri. It might seem early for such proclamations, but I’m confident enough to go on record. Frances McDormand is going to get a nomination for this. Obviously, there are plenty more films to be screened as far as her competition. This includes potential nominees like Viola Davis (Ma Rainey’s Black Bottom), Amy Adams (Hillbilly Elegy), Kate Winslet (Ammonite), and Michelle Pfeiffer (French Exit), among others. We shall see how that plays out, but today’s reviews opens the door for a third McDormand victory. If that were to occur, she would be just the second leading lady to win the prize more than twice. Katherine Hepburn did so four times.

David Strathairn is the other notable actor to discuss. The veteran thespian has one nomination to his credit for Best Actor in 2005’s Good Night, and Good Luck. I have had him ranked at #2 (behind the late Chadwick Boseman for Ma Rainey) in my Supporting Actor estimates for the last two weeks. However, indications are that his role could be smaller than I originally figured. He could still get in, but I’m nowhere near confident. I suspect he won’t be at #2 when I update my projections next Thursday. Whether he’s in the top five remains to be seen (especially with multiple actors vying for spots in Mank, The Trial of the Chicago 7, and One Night in Miami).

Nomadland also seems bound for a Best Picture nod and Zhao is certainly in line for attention with her direction. She would become just the sixth female to compete in that race and she could have company in 2020 with Regina King for Miami. Expect a wider audience to know Zhao’s name shortly as she’s making 2021’s Eternals for Disney/Marvel. Adapted Screenplay appears to be a lock and the movie’s Score and Cinematography and Editing could also be noticed.

Bottom line: Nomadland has stood as a contender for some time. The buzz out today elevates it even more, especially for Zhao and McDormand. My Oscar Watch posts will continue…

The New Mutants Box Office Prediction

***Blogger’s Update (08/27): On the eve of its premiere, I am increasing my prediction for The New Mutants from $4.9 million to $6.9 million. 

The COVID-19 pandemic has altered the release dates for scores of high profile feature films over the past several months. Yet in the case of The New Mutants, its series of delays has become a punchline in Hollywood that far preceded current world events. The film is the latest in the X-Men franchise and it seems 20th Century Fox has absolutely no confidence with it. It’s finally hitting screens after an original planned unveiling in (get this!) April 2018.

Mutants introduces new characters to the X-Men fold in what was originally planned as a potential trilogy. Josh Boone, best known for making The Fault in Our Stars, directs. The cast includes Maisie Williams, Anya Taylor-Joy, Charlie Heaton, Alice Braga, Blu Hunt, and Henry Zaga. Marketed more as a horror flick than comic book adaptation, reports out over the past two years indicate that its studio were not pleased with the final product.

After getting bumped from the spring of 2018, this was pushed to February 2019 and then August 2019 and then April 2020 (this was all during Disney’s acquisition of Fox). After the COVID situation hit, Disney/Fox finally settled on the late August output. Mutants will be closely watched as it is the second American theatrical wide release after Unhinged. 

Prior to COVID, the prospects for Mutants seemed doomed and that hasn’t changed. The X-Men franchise hit a low point in 2019 with Dark Phoenix. Its $32 million debut was easily the lowest of the series (no other X pic had premiered below $50 million). Mutants will blow that record out of the water. For starters, there’s the challenges facing any wide release at the moment (limited theater capacity, major markets still closed, etc…). I also suspect many casual moviegoers simply have no idea that Mutants even exists in the X-Men Universe.

I do not have a screen count for Mutants at press time, but I’m assuming it’s similar to the 2000 theaters that will greet Unhinged this weekend. If that holds, I’m not even confident that Mutants gets above $5 million in its first weekend. Disney and 20th Century Fox seem to be dumping this and I believe audiences will respond in kind.

The New Mutants opening weekend prediction: $6.9 million

X-Men at 20: A Look Back

Twenty years ago today, Bryan Singer’s X-Men arrived in theaters and it’s not hyperbole to call it one of the most influential pictures of the 21st century. The 20th Century Fox release found the comic book genre at a rather low point at the end of that said century. While Blade was a nice size hit in 1998, the years prior found at a lot to be desired with the quality of the genre. 1995 brought us Judge Dredd and 1997 saw the release of Batman and Robin, which found the Caped Crusader with Bat nipples and bad reviews.

X-Men, though it’s hard to remember now, was released at a time where the idea of superhero tales was an uncertain box office prospect. This is two years before Spider-Man broke all kinds of financial records. This is five years prior to Christopher Nolan reinvigorating the Bat franchise with his Dark Knight trilogy. And this was eight years before Robert Downey Jr. was cast as Tony Stark/Iron Man, officially kicking off the Marvel Cinematic Universe.

In the summer of 2000, X-Men was by no means a guaranteed hit. It did, however, have credibility with the behind the scenes talent and cast. Bryan Singer was known for his heralded The Usual Suspects. Acclaimed actors Patrick Stewart, Ian McKellen (fresh off an Oscar nod for Gods and Monsters), Anna Paquin, and Halle Berry were among the onscreen players. And it was another casting decision that provided its most enduring legacy. Russell Crowe, who headlined that summer’s Oscar winner Gladiator, originally turned down the part of Wolverine. Dougray Scott was then cast in the role, but had to drop out when his role as the villain in Mission: Impossible II (also out that summer) prevented him from filming. So it was the unknown Hugh Jackman who donned the claws. He would go on to make it his signature role as he played Logan/Wolverine in numerous sequels and spin-offs (including three stand-alone projects of wildly divergent qualities).

Let’s back up. Before the 2000 release, X-Men was in development for over a decade and a half. At one point, James Cameron was slated to produce with his then wife Kathryn Bigelow attached to direct. Later on, Robert Rodriguez turned the project down. A gander at the pic’s Wikipedia page is an entertaining read (Mariah Carey was in the mix for Storm at one juncture and Angela Bassett was first choice). X-Men was rushed to make its summer release date 20 years ago today after it was originally intended for Christmas 2000.

That rushed feeling does show on up on screen a little, but the overall end result speaks for itself. What occurred two decades ago is a major mark in the comic book movie renaissance that continues to this day. The franchise has certainly had its ups and downs. X2: X-Men United was the first sequel in 2003 and it is generally considered a high point. Three years later, Brett Ratner took over directorial reigns with The Last Stand and (while a huge hit) the quality took a dip. Matthew Vaughn would reestablish critical kudos in rebooting the series in 2011 with First Class (bringing Michael Fassbender, James McAvoy, and Jennifer Lawrence to the screen playing younger counterparts to key characters). Jackman’s first spin-off X-Men Origins: Wolverine faced deserved backlash while 2017’s Logan was lauded and landed an Adapted Screenplay Oscar nomination. And a cheeky and R rated offshoot called Deadpool with Ryan Reynolds would dazzle audiences and critics alike. Last summer’s Dark Phoenix didn’t do any dazzling and was another low ebb in the series. Spin-off The New Mutants has seen release date changes that began in 2018 and it’s pretty much a running joke as to whether it will ever come out.

That long road began in 2000 and has shaped the cinematic universe since. And if you had to mark a spot for the comic book landscape today as it stands now on the screen, it started that day.